A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites
- PMID: 37701567
- PMCID: PMC10493500
- DOI: 10.1016/j.isci.2023.107712
A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites
Abstract
High-grade serous ovarian cancer (HGSOC) is a hormone-related cancer with high mortality and poor prognosis. Based on the transcriptome of 57,444 cells in ascites from 10 patients with HGSOC (including 5 pre-menopausal and 5 post-menopausal patients), we identified 14 cell clusters which were further classified into 6 cell types, including T cells, B cells, NK cells, myeloid cells, epithelial cells, and stromal cells. We discovered an increased proportion of epithelial cells and a decreased proportion of T cells in pre-menopausal ascites compared with post-menopausal ascites. GO analysis revealed the pre-menopausal tumor microenvironments (TME) are closely associated with viral infection, while the post-menopausal TME are mostly related to the IL-17 immune pathway. SPP1/CD44-mediated crosstalk between myeloid cells and B cells, NK cells, and stromal cells mainly present in the pre-menopausal group, while SPP1/PTGER4 -mediated crosstalk between myeloid cells and epithelial cells mostly present in the post-menopausal group.
Keywords: Cancer; Microenvironment.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures








Similar articles
-
Single-cell RNA sequencing reveals the change in cytotoxic NK/T cells, epithelial cells and myeloid cells of the tumor microenvironment of high-grade serous ovarian carcinoma.Discov Oncol. 2024 Sep 9;15(1):417. doi: 10.1007/s12672-024-01290-9. Discov Oncol. 2024. PMID: 39249551 Free PMC article.
-
Integrated analysis of single-cell and bulk transcriptome reveals hypoxia-induced immunosuppressive microenvironment to predict immunotherapy response in high-grade serous ovarian cancer.Front Pharmacol. 2024 Nov 13;15:1450751. doi: 10.3389/fphar.2024.1450751. eCollection 2024. Front Pharmacol. 2024. PMID: 39605915 Free PMC article.
-
[The composition of ascites lymphocytes in high-grade serous ovarian cancer and its correlation with clinical features].Zhonghua Yi Xue Za Zhi. 2021 Aug 10;101(30):2375-2381. doi: 10.3760/cma.j.cn112137-20210211-00409. Zhonghua Yi Xue Za Zhi. 2021. PMID: 34404130 Chinese.
-
Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology.Matrix Biol. 2023 Apr;118:16-46. doi: 10.1016/j.matbio.2023.02.004. Epub 2023 Feb 11. Matrix Biol. 2023. PMID: 36781087 Review.
-
Targeting the Microenvironment in High Grade Serous Ovarian Cancer.Cancers (Basel). 2018 Aug 10;10(8):266. doi: 10.3390/cancers10080266. Cancers (Basel). 2018. PMID: 30103384 Free PMC article. Review.
Cited by
-
PLIN2 Promotes Lipid Accumulation in Ascites-Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling.Adv Sci (Weinh). 2025 Mar;12(12):e2411314. doi: 10.1002/advs.202411314. Epub 2025 Feb 7. Adv Sci (Weinh). 2025. PMID: 39921309 Free PMC article.
-
Two-sample Mendelian Randomization to evaluate the causal relationship between inflammatory arthritis and female-specific cancers.J Transl Med. 2024 Oct 24;22(1):962. doi: 10.1186/s12967-024-05765-9. J Transl Med. 2024. PMID: 39449068 Free PMC article.
-
Sex bias in tumor immunity: insights from immune cells.Theranostics. 2025 Mar 31;15(11):5045-5072. doi: 10.7150/thno.106465. eCollection 2025. Theranostics. 2025. PMID: 40303343 Free PMC article. Review.
-
AEG-1 expression analysis in epithelial ovarian carcinoma: Uncovering distinctions between high-grade and low-grade serous carcinoma.Mol Clin Oncol. 2025 Jun 4;23(2):70. doi: 10.3892/mco.2025.2865. eCollection 2025 Aug. Mol Clin Oncol. 2025. PMID: 40529100 Free PMC article.
-
Global burden and trends in pre- and post-menopausal gynecological cancer from 1990 to 2019, with projections to 2040: a cross-sectional study.Int J Surg. 2025 Jan 1;111(1):891-903. doi: 10.1097/JS9.0000000000001956. Int J Surg. 2025. PMID: 39093825 Free PMC article.
References
-
- Siegel R.L., Miller K.D., Wagle N.S., Jemal A. Cancer statistics, 2023. CA A Cancer J. Clin. 2023;73:17–48. - PubMed
-
- Miller K.D., Nogueira L., Devasia T., Mariotto A.B., Yabroff K.R., Jemal A., Kramer J., Siegel R.L. Cancer treatment and survivorship statistics, 2022. CA A Cancer J. Clin. 2022;72:409–436. - PubMed
-
- Lheureux S., Braunstein M., Oza A.M. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA A Cancer J. Clin. 2019;69:280–304. - PubMed
-
- Sisodia R.C., Del Carmen M.G. Lesions of the Ovary and Fallopian Tube. N. Engl. J. Med. 2022;387:727–736. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous